Chemical assays of bioactive molecules (in urine, plasma, saliva, etc.). Added value In vitro estimation of ADME/TOX indicators.
Development of molecular biointeraction models. Computational simulation methods (“in silico” via “Molecular Docking”). Pharmacophores. QSAR.
The development of new methodologies for the preparation of fluorinated alkynes has allowed the generation of new families of these compounds and the study of their reactivity in the presence of gold salts, ruthenium, palladium and cobalt complexes. These alkynes have shown new reactivity patterns.
The use of terphenyls as peptidomimetics has made it possible, in collaboration with Doctor José Gallego, to develop a new family of these compounds as potential drugs in the fight against HIV.
